Sign In
Buy CDNA
$22.31
+0.240 (+1.09%)
At Close: Jun 03, 2026
CareDx: 1Q Earnings Snapshot
11:06pm, Thursday, 30'th Apr 2020
SOUTH SAN FRANCISCO, Calif. (AP) _ CareDx Inc. (CDNA) on Thursday reported a loss of $5.8 million in its first quarter.
On a per-share basis, the South San Francisco, California-based company said it
CareDx Q1 EPS $0.00 Misses $0.03 Est., Sales $38.400M Beat $37.990M Estimate
08:14pm, Thursday, 30'th Apr 2020CareDx Reports First Quarter 2020 Results
08:05pm, Thursday, 30'th Apr 2020
SOUTH SAN FRANCISCO, Calif., April 30, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
11:19am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
12:00am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 29)
• Arvinas Inc (NASDAQ...
Notable earnings after Thursday's close
09:35pm, Wednesday, 29'th Apr 2020
AAPL, AEM, AJG, ALEX, AMGN, AMZN, ASGN, ATR, ATUS, BAND, BL, BLDR, BRKS, CDNA, CLGX, COG, COLM, CRY, CUZ, CXO, CXP, EBS, EGP, EIX, EMN, EXPO, FBHS, FHI, FMBI, FND, FTAI, FTV, FWRD, GILD, GLPI, HP, HTH
CareDx Q1 2020 Earnings Preview
09:35pm, Wednesday, 29'th Apr 2020
CareDx (NASDAQ:CDNA) is scheduled to announce Q1 earnings results on Thursday, April 30th, after market close.The consensus EPS Estimate is $0.03 (-40.0% Y/Y) and the consensus Revenue Estimate is $38
Perkins Capital Management Inc Buys Interpace Biosciences Inc, CareDx Inc, Gilead Sciences Inc, ...
12:00am, Wednesday, 29'th Apr 2020CareDx Inc (NASDAQ:CDNA) Expected to Announce Earnings of -$0.02 Per Share
09:52am, Tuesday, 28'th Apr 2020
Equities analysts expect CareDx Inc (NASDAQ:CDNA) to announce ($0.02) earnings per share for the current quarter, according to Zacks. Three analysts have made estimates for CareDx’s earnings, with t
We’re Not Worried About CareDx’s (NASDAQ:CDNA) Cash Burn
12:11pm, Monday, 27'th Apr 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
CareDx Engages European Lab Community in Virtual Meetings
11:00am, Monday, 27'th Apr 2020
SOUTH SAN FRANCISCO, Calif., April 27, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
CareDx Engages European Lab Community in Virtual Meetings
11:00am, Monday, 27'th Apr 2020
Leaders in HLA and transplant laboratory solutions will present at CareDx virtual symposiums originally planned for EFI
CareDx Inc (NASDAQ:CDNA) Expected to Announce Quarterly Sales of $38.23 Million
05:14am, Monday, 27'th Apr 2020
Wall Street analysts expect CareDx Inc (NASDAQ:CDNA) to post sales of $38.23 million for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for CareDx’s earnings, w
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
08:37pm, Sunday, 26'th Apr 2020
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. Two FDA approvals came through this week, with Immunomedics, Inc.'s
